Dow Down 0.36% Nasdaq Down 0.53%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
2.50 Down 0.01(0.40%) Sep 12, 4:03PM EDT
Prev Close:2.51
Open:2.51
Bid:2.28 x 1000
Ask:4.10 x 100
1y Target Est:5.50
Beta:1.4
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.50 - 2.59
52wk Range:2.35 - 5.30
Volume:262,696
Avg Vol (3m):369,391
Market Cap:232.05M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PLX

Comparison

Symbol% ChgMkt Cap
PLXDown 0.40%232.05M
SHPGUp 0.19%50.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.21
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback